t," adds Henry.
MassMutual Financial Group is a marketing name for Massachusetts Mutual
Life Insurance Company (MassMutual) and its affiliated companies and sales
representatives. MassMutual and its subsidiaries had more than $500 billion
in assets under management at year-end 2007. Assets under management
include assets and certain external investment funds managed by
MassMutual's subsidiaries.
Founded in 1851, MassMutual is a mutually owned financial protection,
accumulation and income management company headquartered in Springfield,
Mass. MassMutual's major affiliates include: OppenheimerFunds, Inc.; Babson
Capital Management LLC; Baring Asset Management Limited; Cornerstone Real
Estate Advisers LLC; MML Investors Services, Inc., member FINRA and SIPC
(http://www.finra.org and http://www.sipc.org); MassMutual International LLC and The
MassMutual Trust Company, FSB. MassMutual is on the Internet at
http://www.massmutual.com.
Contact: Mark Cybulski
413-744-5427
'/>"/>SOURCE MassMutual Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources2.
MassMutual Agent Honored by Insurance Industry for Extraordinary Service to Client3.
Andy Ambrose Joins MassMutuals Institutional Sales Team for Retirement Services4.
MassMutuals Center for Behavioral Research(sm) Releases White Paper Regarding Automatic Features in Retirement Plans5.
MassMutual Offers Free Letter of Intent Template to People with Disabilities and Their Families, Caregivers6.
MassMutuals Center for Behavioral Research(SM) Releases White Paper on Best Practices in Education Campaigns7.
HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness8.
CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael9.
UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West10.
HEI, Inc. Announces Sale of RFID Division Assets11.
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)